Parthenolide

N/A

Report date: 2026/04/18 20:00:19
NME

Base Information

Drug NameParthenolide
Drug Alias NameNSC-157035
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsCognitive DysfunctionCognition DisordersAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAshbury Biologicals
China Registration ClassN/A

Develop Information

Active CompaniesMassachusetts General Hospital
Inactive CompaniesAshbury Biologicals
Active IndicationsCognitive DysfunctionCognition DisordersAlzheimer Disease
Inactive IndicationsLymphoma

Other Information

ATC CodeN/A
Related LinksWikipedia